Cargando…
HIV-1 latency in actively dividing human T cell lines
BACKGROUND: Eradication of HIV-1 from an infected individual cannot be achieved by current drug regimens. Viral reservoirs established early during the infection remain unaffected by anti-retroviral therapy and are able to replenish systemic infection upon interruption of the treatment. Therapeutic...
Autores principales: | Jeeninga, Rienk E, Westerhout, Ellen M, van Gerven, Marja L, Berkhout, Ben |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2387167/ https://www.ncbi.nlm.nih.gov/pubmed/18439275 http://dx.doi.org/10.1186/1742-4690-5-37 |
Ejemplares similares
-
Latency profiles of full length HIV-1 molecular clone variants with a subtype specific promoter
por: van der Sluis, Renée M, et al.
Publicado: (2011) -
Differential proviral latency of the HIV-1 subtypes B and AE
por: van der Sluis, Renée M, et al.
Publicado: (2011) -
Transient CRISPR-Cas Treatment Can Prevent Reactivation of HIV-1 Replication in a Latently Infected T-Cell Line
por: Liu, Ye, et al.
Publicado: (2021) -
RNAi strategies to silence HIV-1
por: Eekels, Julia, et al.
Publicado: (2011) -
HIV-1 latency in activated T-cells
por: Berkhout, Ben
Publicado: (2013)